Evidence map›Paper›PMID 34452390›Full record

ArticleViruses2021

The Algerian Chapter of SARS-CoV-2 Pandemic: An Evolutionary, Genetic, and Epidemiological Prospect.

Safia Zeghbib, Balázs A Somogyi, Brigitta Zana, Gábor Kemenesi, Róbert Herczeg, Fawzi Derrar, Ferenc Jakab

Abstract read
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Safia ZeghbibNational Laboratory of Virology, Szentágothai Research Centre, University of Pécs, 7624 Pécs, Hungary.
Balázs A SomogyiNational Laboratory of Virology, Szentágothai Research Centre, University of Pécs, 7624 Pécs, Hungary.
Brigitta ZanaNational Laboratory of Virology, Szentágothai Research Centre, University of Pécs, 7624 Pécs, Hungary.ORCID 0000-0002-3503-8901
Gábor KemenesiNational Laboratory of Virology, Szentágothai Research Centre, University of Pécs, 7624 Pécs, Hungary.ORCID 0000-0001-9775-3065
Róbert HerczegGenomics and Bioinformatics Core Facility, Bioinformatics Research Group, Szentágothai Research Centre, University of Pécs, 7624 Pécs, Hungary.
Fawzi DerrarNational Influenza Centre, Viral Respiratory Laboratory, Institut Pasteur d'Algérie, Algiers 16000, Algeria.
Ferenc JakabNational Laboratory of Virology, Szentágothai Research Centre, University of Pécs, 7624 Pécs, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To explore the SARS-CoV-2 pandemic in Algeria, a dataset comprising ninety-five genomes originating from SARS-CoV-2 sampled from Algeria and other countries worldwide, from 24 December 2019, through 4 March 2021, was thoroughly examined. While performing a multi-component analysis regarding the Algerian outbreak, the toolkit of phylogenetic, phylogeographic, haplotype, and genomic analysis were effectively implemented. We estimated the Time to the Most Recent Common Ancestor (TMRCA) in reference to the Algerian pandemic and highlighted the multiple introductions of the disease and the missing data depicted in the transmission loop. In addition, we emphasized the significant role played by local and international travels in disease dissemination. Most importantly, we unveiled mutational patterns, the effect of unique mutations on corresponding proteins, and the relatedness regarding the Algerian sequences to other sequences worldwide. Our results revealed individual amino-acid replacements such as the deleterious replacement A23T in the

Indexed as

Evolution, MolecularAlgeriaCOVID-19Genome, ViralGenomicsHaplotypesHumansMutationPandemicsPhylogenyPhylogeographySARS-CoV-2Saudi ArabiaTravelevolutionhaplotype network analysismutationsphylogenyphylogeographySARS-CoV-2selection pressuretransmission route

Identifiers

PMID34452390
PMCPMC8402747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.